ANL
Price
$1.47
Change
-$0.03 (-2.00%)
Updated
Jun 18 closing price
Capitalization
54.24M
48 days until earnings call
RIGL
Price
$19.36
Change
+$0.20 (+1.04%)
Updated
Jun 18 closing price
Capitalization
346.01M
Interact to see
Advertisement

ANL vs RIGL

Header iconANL vs RIGL Comparison
Open Charts ANL vs RIGLBanner chart's image
Adlai Nortye
Price$1.47
Change-$0.03 (-2.00%)
Volume$16.71K
Capitalization54.24M
Rigel Pharmaceuticals
Price$19.36
Change+$0.20 (+1.04%)
Volume$142.46K
Capitalization346.01M
ANL vs RIGL Comparison Chart in %
Loading...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. RIGL commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and RIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (ANL: $1.47 vs. RIGL: $19.36)
Brand notoriety: ANL and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 81% vs. RIGL: 77%
Market capitalization -- ANL: $54.24M vs. RIGL: $346.01M
ANL [@Biotechnology] is valued at $54.24M. RIGL’s [@Biotechnology] market capitalization is $346.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANL and RIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RIGL’s TA Score shows that 3 TA indicator(s) are bullish.

  • RIGL’s TA Score: 3 bullish, 5 bearish.

Price Growth

ANL (@Biotechnology) experienced а -11.98% price change this week, while RIGL (@Biotechnology) price change was -8.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

ANL is expected to report earnings on Aug 07, 2025.

RIGL is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($346M) has a higher market cap than ANL($54.2M). RIGL YTD gains are higher at: 15.101 vs. ANL (-45.255). RIGL has higher annual earnings (EBITDA): 48.5M vs. ANL (-49.89M). ANL has more cash in the bank: 98M vs. RIGL (77.1M). ANL has less debt than RIGL: ANL (39.5M) vs RIGL (61.1M). RIGL has higher revenues than ANL: RIGL (203M) vs ANL (5M).
ANLRIGLANL / RIGL
Capitalization54.2M346M16%
EBITDA-49.89M48.5M-103%
Gain YTD-45.25515.101-300%
P/E RatioN/A9.26-
Revenue5M203M2%
Total Cash98M77.1M127%
Total Debt39.5M61.1M65%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALSAX9.660.07
+0.73%
Alger Small Cap Growth A
JHSGX28.040.05
+0.18%
JHancock U.S. Growth R4
INFFX8.90N/A
N/A
Tortoise Energy Infrastructure and Inc C
HEMDX10.08-0.01
-0.10%
Janus Henderson Emerging Markets D
MKVCX15.54-0.02
-0.13%
MFS International Large Cap Value C

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and RIGL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.00%
RIGL - ANL
25%
Poorly correlated
+1.04%
FGHQF - ANL
25%
Poorly correlated
N/A
LENZ - ANL
22%
Poorly correlated
+3.69%
NVCT - ANL
21%
Poorly correlated
-0.74%
VCEL - ANL
21%
Poorly correlated
+0.67%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with DNLI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+1.04%
DNLI - RIGL
42%
Loosely correlated
-3.63%
MNMD - RIGL
41%
Loosely correlated
+5.66%
WVE - RIGL
38%
Loosely correlated
+4.70%
TRDA - RIGL
38%
Loosely correlated
-5.13%
KYMR - RIGL
38%
Loosely correlated
+0.19%
More